A role for cysteine-rich 61 in the angiogenic switch during the estrous cycle in cows: Regulation by prostaglandin F 2alpha

Biology of Reproduction

Volumn 85, Issue 2, 2011, Pages 261-268

  Zhang, Bo ^a,b   Tsang, Paul C W ^c   Pate, Joy L ^d,e   Moses, Marsha A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NEW HAMPSHIRE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Angiogenesis; Corpus luteum; CYR61; Endothelial cells; Luteal regression; PGF2a

Indexed keywords

CYSTEINE RICH PROTEIN 61; ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA; PROSTAGLANDIN F2 ALPHA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COW; ENDOTHELIUM CELL; ESTRUS CYCLE; FEMALE; GENE EXPRESSION; LUTEAL CELL; LUTEAL DERIVED ENDOTHELIAL CELL; LUTEAL STEROIDOGENIC CELL; LUTEOLYSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; CATTLE; CELLS, CULTURED; CORPUS LUTEUM; CYSTEINE-RICH PROTEIN 61; DINOPROST; ENDOTHELIAL CELLS; ESTROUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; METALLOENDOPEPTIDASES; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 80052521704     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.110.086645     Document Type: Article

References (69)

1. Augustin HG, Braun K, Telemenakis I, Modlich U, Kuhn W. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 1995; 147:339-351.
2. Reynolds LP, Grazul-Bilska AT, Redmer DA. Angiogenesis in the corpus luteum. Endocrine 2000; 12:1-9.
3. Zhang B, Yan L, Tsang PC, Moses MA. Matrix metalloproteinase-2 (MMP-2) expression and regulation by tumor necrosis factor α (TNFα) in the bovine corpus luteum. Mol Reprod Dev 2005; 70:122-132.
4. Murdoch WJ, Gottsch ML. Proteolytic mechanisms in the ovulatory folliculo-luteal transformation. Connect Tissue Res 2003; 44:50-57.
5. Pederson E. Histogenesis of luteal tissue of the albino rat. Am J Anat 1951; 88:397-427.
6. Parry DM, Willcox DL, Thorburn GD. Ultrastructural and cytochemical study of the bovine corpus luteum. J Reprod Fertil 1980; 60:349-357.
7. Cavender JL, Murdoch WJ. Morphological studies of the microcirculatory system of periovulatory ovine follicles. Biol Reprod 1988; 39:989-997.
8. Wiltbank MC, Dysko RC, Gallagher KP, Keyes PL. Relationship between blood flow and steroidogenesis in the rabbit corpus luteum. J Reprod Fertil 1988; 84:513-520.
9. Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G, Harper J, Tamvakopoulos G, Moses MA. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A 2000; 97:3884-3889.
10. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2:737-744.
11. Dharmarajan AM, Bruce NW, Meyer GT. Quantitative ultrastructural characteristics relating to transport between luteal cell cytoplasm and blood in the corpus luteum of the pregnant rat. Am J Anat 1985; 172:87- 99.
12. Jablonka-Shariff A, Grazul-Bilska AT, Redmer DA, Reynolds LP. Growth and cellular proliferation of ovine corpora lutea throughout the estrous cycle. Endocrinology 1993; 133:1871-1879.
13. Smith MF, McIntush EW, Smith GW. Mechanisms associated with corpus luteum development. J Anim Sci 1994; 72:1857-1872.
14. Zheng J, Redmer DA, Reynolds LP. Vascular development and heparinbinding growth factors in the bovine corpus luteum at several stages of the estrous cycle. Biol Reprod 1993; 49:1177-1189.
15. Duncan WC. The human corpus luteum: remodeling during luteolysis and maternal recognition of pregnancy. Rev Reprod 2000; 5:12-17.
16. McCracken JA, Custer EE, Lamsa JC. Luteolysis: a neuroendocrine-mediated event. Physiol Rev 1999; 79:263-323.
17. Davis JS, Rueda BR, Spanel-Borowski K. Microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003; 1:89.
18. Fraser HM, Wulff C. Angiogenesis in the corpus luteum. Reprod Biol Endocrinol 2003; 1:88.
19. Zhang B, Yan L, Moses MA, Tsang PC. Bovine membrane-type 1 matrix metalloproteinase: molecular cloning and expression in the corpus luteum. Biol Reprod 2002; 67:99-106.
20. Zhang B, Moses MA, Tsang PC. Temporal and spatial expression of tissue inhibitors of metalloproteinases 1 and 2 (TIMP-1 and -2) in the bovine corpus luteum. Reprod Biol Endocrinol 2003; 1:85.
21. Yan Z, Weich HA, Bernart W, Breckwoldt M, Neulen J. Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J Clin Endocrinol Metab 1993; 77:1723-1725.
22. Yamamoto S, Konishi I, Tsuruta Y, Nanbu K, Mandai M, Kuroda H, Matsushita K, Hamid AA, Yura Y, Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol Endocrinol 1997; 11:371- 381.
23. Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 1997; 138:4748- 4756.
24. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril 2000; 74:429-438.
25. Gospodarowicz D, Cheng J, Lui GM, Baird A, Esch F, Bohlen P. Corpus luteum angiogenic factor is related to fibroblast growth factor. Endocrinology 1985; 117:2383-2391.
26. Fraser HM, Bell J, Wilson H, Taylor PD, Morgan K, Anderson RA, Duncan WC. Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. J Clin Endocrinol Metab 2005; 90:427-434.
27. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60.
28. Berisha B, Schams D, Kosmann M, Amselgruber W, Einspanier R. Expression and tissue concentration of vascular endothelial growth factor, its receptors, and localization in the bovine corpus luteum during estrous cycle and pregnancy. Biol Reprod 2000; 63:1106-1114.
29. Perbal B. CCN proteins: multifunctional signaling regulators. Lancet 2004; 363:62-64.
30. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999; 248:44-57.
31. Wandji SA, Gadsby JE, Barber JA, Hammond JM. Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis. Endocrinology 2000; 141:2648-2657.
32. Goldberg MJ, Moses MA, Tsang PC. Identification of matrix metalloproteinases and metalloproteinase inhibitors in bovine corpora lutea and their variation during the estrous cycle. J Anim Sci 1996; 74:849-857.
33. Cannon MJ, Pate JL. Expression and regulation of interferon gammainducible proteasomal subunits LMP7 and LMP10 in the bovine corpus luteum. Biol Reprod 2003; 68:1447-1454.
34. Pate JL, Condon WA. Effects of serum and lipoproteins on steroidogenesis in cultured bovine luteal cells. Mol Cell Endocrinol 1982; 28:551-562.
35. Pru JK, Lynch MP, Davis JS, Rueda BR. Signaling mechanisms in tumor necrosis factor α-induced death of microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 2003; 1:17.
36. Gashaw I, Stiller S, Boing C, Kimmig R, Winterhager E. Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium. Endocrinology 2008; 149:2261-2269.
37. Ginther OJ, Araujo RR, Palhao MP, Rodrigues BL, Beg MA. Necessity of sequential pulses of prostaglandin F2α for complete physiologic luteolysis in cattle. Biol Reprod 2009; 80:641-648.
38. Neuvians TP, Berisha B, Schams D. Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum. Mol Reprod Dev 2004; 67:389-395.
39. Kolesnikova TV, Lau LF. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene 1998; 16:747-754.
40. Redmer DA, Grazul AT, Kirsch JD, Reynolds LP. Angiogenic activity of bovine corpora lutea at several stages of luteal development. J Reprod Fertil 1988; 82:627-634.
41. Beal WE, Milvae RA, Hansel W. Estrous cycle length and plasma progesterone concentrations following administration of prostaglandin F2α early in the bovine estrous cycle. J Reprod Fertil 1980; 59:393-396.
42. Inskeep EK. Potential uses of prostaglandins in control of reproductive cycles of domestic animals. J Anim Sci 1973; 36:1149-1157.
43. Shirasuna K, Sasahara K, Matsui M, Shimizu T, Miyamoto A. Prostaglandin F2α differentially affects mRNA expression relating to angiogenesis, vasoactivation and prostaglandins in the early and mid corpus luteum in the cow. J Reprod Dev 2010; 56:428-436.
44. Tsai SJ, Wiltbank MC. Prostaglandin F2α regulates distinct physiological changes in early and mid-cycle bovine corpora lutea. Biol Reprod 1998; 58:346-352.
45. Miyamoto A, von Lutzow H, Schams D. Acute actions of prostaglandin F2α, E2, and I2 in microdialyzed bovine corpus luteum in vitro. Biol Reprod 1993; 49:423-430.
46. Okuda K, Uenoyama Y, KW Lee, R Sakumoto, Skarzynski D. Progesterone stimulation by prostaglandin F2α involves the protein kinase C pathway in cultured bovine luteal cells. J Reprod Dev 1998; 44:79-84.
47. Silva PJ, Juengel JL, Rollyson MK, Niswender GD. Prostaglandin metabolism in the ovine corpus luteum: catabolism of prostaglandin F2α (PGF2α) coincides with resistance of the corpus luteum to PGF2α. Biol Reprod 2000; 63:1229-1236.
48. Cavicchio VA, Pru JK, Davis BS, Davis JS, Rueda BR, Townson DH. Secretion of monocyte chemoattractant protein-1 by endothelial cells of the bovine corpus luteum: regulation by cytokines but not prostaglandin F2α. Endocrinology 2002; 143:3582-3589.
49. Anderson LE, Wu YL, Tsai SJ, Wiltbank MC. Prostaglandin F2α receptor in the corpus luteum: recent information on the gene, messenger ribonucleic acid, and protein. Biol Reprod 2001; 64:1041-1047.
50. Mamluk R, Chen D, Greber Y, Davis JS, Meidan R. Characterization of messenger ribonucleic acid expression for prostaglandin F2α and luteinizing hormone receptors in various bovine luteal cell types. Biol Reprod 1998; 58:849-856.
51. Meidan R, Levy N, Kisliouk T, Podlovny L, Rusiansky M, Klipper E. The yin and yang of corpus luteum-derived endothelial cells: balancing life and death. Domest Anim Endocrinol 2005; 29:318-328.
52. Spanel-Borowski K, van der Bosch J. Different phenotypes of cultured microvessel endothelial cells obtained from bovine corpus luteum. Study by light microscopy and by scanning electron microscopy (SEM). Cell Tissue Res 1990; 261:35-47.
53. Townson D. Immune cell-endothelial cell interactions in the bovine corpus luteum. Integrative and Comparative Biology 2006; 46:1055-1059.
54. Liptak AR, Sullivan BT, Henkes LE, Wijayagunawardane MP, Miyamoto A, Davis JS, Rueda BR, Townson DH. Cooperative expression of monocyte chemoattractant protein 1 within the bovine corpus luteum: evidence of immune cell-endothelial cell interactions in a coculture system. Biol Reprod 2005; 72:1169-1176.
55. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 1989; 86:2863-2867.
56. Opgenorth TJ, Wu-Wong JR, Shiosaki K. Endothelin-converting enzymes. FASEB J 1992; 6:2653-2659.
57. Girsh E, Wang W, Mamluk R, Arditi F, Friedman A, Milvae RA, Meidan R. Regulation of endothelin-1 expression in the bovine corpus luteum: elevation by prostaglandin F 2α. Endocrinology 1996; 137:5191-5196.
58. Wright MF, Sayre B, Inskeep EK, Flores JA. Prostaglandin F2α regulation of the bovine corpus luteum endothelin system during the early and midluteal phase. Biol Reprod 2001; 65:1710-1717.
59. Levy N, Gordin M, Mamluk R, Yanagisawa M, Smith MF, Hampton JH, Meidan R. Distinct cellular localization and regulation of endothelin-1 and endothelin-converting enzyme-1 expression in the bovine corpus luteum: implications for luteolysis. Endocrinology 2001; 142:5254-5260.
60. Acosta TJ, Yoshizawa N, Ohtani M, Miyamoto A. Local changes in blood flow within the early and midcycle corpus luteum after prostaglandin F2α injection in the cow. Biol Reprod 2002; 66:651-658.
61. Mo FE, Muntean AG, Chen CC, Stolz DB, Watkins SC, Lau LF. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol 2002; 22:8709-8720.
62. Kireeva ML, Mo FE, Yang GP, Lau LF. CYR61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996; 16:1326-1334.
63. Kireeva ML, Lam SC, Lau LF. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αvβ3. J Biol Chem 1998; 273:3090-3096.
64. Babic AM, Kireeva ML, Kolesnikova TV, Lau LF. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A 1998; 95:6355-6360.
65. Fataccioli V, Abergel V, Wingertsmann L, Neuville P, Spitz E, Adnot S, Calenda V, Teiger E. Stimulation of angiogenesis by CYR61 gene: a new therapeutic candidate. Hum Gene Ther 2002; 13:1461-1470.
66. Tsai MS, Bogart DF, Castaneda JM, Li P, Lupu R. CYR61 promotes breast tumorigenesis and cancer progression. Oncogene 2002; 21:8178-8185.
67. Chen CC, Mo FE, Lau LF. The angiogenic factor CYR61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem 2001; 276:47329-47337.
68. Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis 2001; 4:289-298.
69. Tsang PC, Poff JP, Boulton EP, Condon WA. Four-day-old bovine corpus luteum: progesterone production and identification of matrix metalloproteinase activity in vitro. Biol Reprod 1995; 53:1160-1168.